Qiming Venture Partners has led a $37 million Series B round for Insilico Medicine, a Hong Kong-based drug development company that uses artificial intelligence (AI).
Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Eight Roads, F-Prime Capital, Pavilion Capital, and Bold Capital Partners also contributed. Previous investors include Hong Kong’s Deep Knowledge...
Michael Granoff, founder and CEO of Pomona Capital, discusses raising capital from Asian LPs, how GPs can be differentiated in a crowded secondaries market, and why he’s not keen on fund restructurings
Japanese mid-market buyout firm Tokio Marine Capital is spinning out from its corporate parent to form an independent investment manager known as T Capital Partners.
Centurium Capital, CITIC Capital and Hillhouse Capital are part of an investor group targeting a $4.6 billion take-private of China Biologic – just over a year after committing new equity to the US-listed company to protect it from other would-be acquirers.
Groww, an Indian financial technology provider focused on mutual fund investment services, has raised a $21.4 million Series B round led by US-based Ribbit Capital.